Source: International Congress 2015 – Advances in the future treatment of severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Matthew Loza (Spring House, United States of America), Matthew Loza, Irina Strambu, Michel Laviolette, David Singh, J. Mark FitzGerald, Stephen Lam, Steven Steven Kelsen, Andreas Eich, Andrea Ludwig-Sengpiel, Geoffrey Chupp, Vibeke Backer, Celeste Porsbjerg, Pierre-Olivier Girodet, Patrick Berger, Richard Leigh, Joel Kline, Mark Dransfield, William Calhoun, Azra Hussaini, Sumita Khatri, Pascal Chanez, Vedrana Susulic, Elliot Barnathan, Kevin Petty, Mark Curran, Anuk Das, Carrie Brodmerkel, Frédéric Baribaud, Philip Silkoff. Clinical biomarkers identify T-helper 2 status defined by mucosal CCL26 in the ADEPT-asthma study. Eur Respir J 2015; 46: Suppl. 59, 1771

Member's Comments

No comment yet.

Related content which might interest you: ADEPT-derived, U-BIOPRED validated asthma clinical clusters with Th2 and non-Th2 phenotypes Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Clinical and pathophysiological features of asthma phenotypes Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Peripheral pathological ILC2: An inflammatory indicator for the assessment of asthma control in clinics Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 The identification of asthma phenotypes by categorical PCA: Combinatorial analysis of clinical parameters and dysfunctional blood eosinophils Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 IL-25 receptor expression on basophil membrane is related to phenotype and severity of asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 Th2 subsetting of U-BIOPRED asthma subjects based on airway transciptomic profiles Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 The first U-BIOPRED blood handprint of severe asthma Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Mast cell gene signature enrichment associates with late-onset severe asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015